MedPath

The effect of phototherapy and oral Simvastatin in treatment of vitiligo

Phase 2
Conditions
Vitiligo.
Vitiligo
Registration Number
IRCT20150825023753N11
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

The patients with vitiligo
Age above 14 years old

Exclusion Criteria

Patients with systemic diseases
Patients who use other therapeutic methods except light therapy
Patients with any liver disease
Patients with any kidney disease
Pregnant and lactating women
History of allergy to phototherapy
Taking medication that has interactions with simvastatin

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The amount of melanin pigment in the skin. Timepoint: Assessment the amount of melanin pigment at the start of the study and at the end of the first, second, third and fourths month after beginning the treatment. Method of measurement: Vitiligo Area Scoring Index (VASI Score).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath